Combined low-dose everolimus and low-dose tacrolimus after Alemtuzumab induction therapy: a randomized prospective trial in lung transplantation

Peer Review reports

Original Submission
17 Aug 2020	Submitted	Original manuscript
21 Oct 2020	Reviewed	Reviewer Report - Kirsty Loudon
Resubmission - Version 2
	Submitted	Manuscript version 2
Publishing
23 Oct 2020	Editorially accepted
4 Jan 2021	Article published	10.1186/s13063-020-04843-9

Back to article page